Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5303]

Molecular profiling identifies new high-risk subtype of paediatric liver cancer

Molecular profiling identifies new high-risk subtype of paediatric liver cancer

Study reveals cause, potential precision therapies for aggressive type of lymphoma

Study reveals cause, potential precision therapies for aggressive type of lymphoma

Researchers find new mechanism to turn on cancer-killing T cells

Researchers find new mechanism to turn on cancer-killing T cells

A nanoparticle and inhibitor trigger the immune system, outsmarting brain cancer

A nanoparticle and inhibitor trigger the immune system, outsmarting brain cancer

Immunotherapy may play role in treating non-metastatic gastroesophageal cancer

Immunotherapy may play role in treating non-metastatic gastroesophageal cancer

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment

First mutation-targeted bladder cancer drug may be under-used

First mutation-targeted bladder cancer drug may be under-used

PARP inhibitor treatment potential for some prostate cancer brain metastases

PARP inhibitor treatment potential for some prostate cancer brain metastases

The combination makes the difference: New therapeutic approach against breast cancer

The combination makes the difference: New therapeutic approach against breast cancer

Ribociclib offers more life in the first-line setting for postmenopausal HR+/HER2- advanced breast cancer patients

Ribociclib offers more life in the first-line setting for postmenopausal HR+/HER2- advanced breast cancer patients

More from ecancer